Robert Soliva

Robert Soliva

Company: Oryzon Genomics

Job title: Head of Drug Discovery


Panel Discussion – HDAC3, BET, RNA, So Many Targets – Exploring New Potential in Well Known Targets to Create New Value & Diversify Pipelines 9:30 am

Discuss disease positioning and the importance of this in creating value out of your existing IP Highlight the criteria you should consider before exploring a new therapeutic area Explore current examples of therapeutics that have been reused in this way How can this potential be capitalized on for both oncological and non-oncological indications? Dr. NikhilRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.